Moderna Inc could take months to begin shipping a COVID-19 vaccine that works specifically against the Omicron variant, its chief executive officer, StÃ©phane Bancel, told CNBC on Monday.
The Omicron variant carries a very high global risk of surges, the WHO warned on Monday, as more countries reported cases.
Bancel told CNBC in an interview that the efficacy of COVID-19 vaccines against the variant was currently not known, and that there should be more clarity in about two weeks.
Moderna said on Friday it was working to advance a booster candidate tailored to the new variant and has also been testing a higher dose of its existing booster and to study other booster candidates designed to protect against multiple variants.
Separately, rivals Pfizer and BioNTech, and Johnson & Johnson have also said they have begun testing their vaccines against the new variant.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.